-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.00120.88% Upside
Vanda Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Vanda Pharmaceuticals Inc.?
Vanda Pharmaceuticals Inc. has been rated by research analysts at Cantor Fitzgerald in the past 90 days.